Bing Chen
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Bing Chen has a total of 57 co-authors. Here are the top co-authors by number of shared publications:
Yifeng Pan
Department of Vascular Surgery, The Second Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, 310009, China; State Key Laboratory of Transvascular Implantation Devices, The Second Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, 310009, China
6 shared publicationsChangming Shao
The Second Affiliated Hospital of Zhejiang University's Medical College, Department of Vascular Surgery, Hangzhou, Zhejiang, China
2 shared publicationsJue-Jue Wang
Department of Nursing, The Second Affiliated Hospital of Zhejiang University School of Medicine, Zhejiang, Hangzhou, Zhejiang, China
2 shared publicationsShuangxiang Lin
Department of Radiology, The Second Affiliated Hospital Zhejiang University School of Medicine, Hangzhou, People’s Republic Of China
2 shared publicationsYan-Fei Feng
Department of Vascular Surgery, The Second Affiliated Hospital, Zhejiang University School of Medicine, Zhejiang Province, Hangzhou, China
2 shared publicationsYi-Feng Pan
Department of Vascular Surgery, The Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou 310009, Zhejiang Province, China
2 shared publications
Latest Publications
- Open Access
- 23 October 2026
- Published by Elsevier in European Journal of Pharmacology
- Vol. 1039, 179477
Tetramethylpyrazine enhances angiogenesis in diabetic hindlimb ischemia by modulating the THBS1/PI3K/AKT signaling axis and reversing aberrant expression of MFN1/FIS1-related mitochondrial fusion-fission proteins
- 23 October 2026
- Published by Elsevier in European Journal of Pharmacology
- Vol. 1039, 179477
Open AccessTetramethylpyrazine enhances angiogenesis in diabetic hindlimb ischemia by modulating the THBS1/PI3K/AKT signaling axis and reversing aberrant expression of MFN1/FIS1-related mitochondrial fusion-fission proteins
- Open Access
- 7 October 2026
- Published by Springer Nature in Insights into Imaging
- Vol. 17 (1) , 241
Contralateral-controlled thigh muscle biomarkers on CT angiography for prediction of 1-year restenosis after endovascular therapy for unilateral peripheral artery disease
Objective: To develop and internally validate a model using contralateral-controlled thigh muscle biomarkers, measured on routine computed tomography angiography (CTA), to predict clinically driven, DSA-confirmed 1-year restenosis after endovascular therapy for unilateral peripheral artery disease (PAD). Materials and methods: In this retrospective cohort study, 378 patients with unilateral PAD undergoing endovascular therapy and having baseline and 1-year follow-up CTA were included. Mid-thigh skeletal muscle cross-sectional area and whole-thigh muscle volume were quantified bilaterally with semi-automated software. Contralateral-controlled biomarkers (affected minus contralateral) were derived to isolate limb-specific ischemic effects. The primary endpoint was clinically driven 1-year restenosis (≥ 50%) confirmed by DSA. Results: Among 378 patients, 162 (43%) developed restenosis at a median follow-up of 12.5 months. Contralateral-controlled muscle asymmetry was independently associated with restenosis after adjustment for lesion length, baseline stenosis degree, Fontaine stage, disease duration, and TASC II classification (OR 1.43, 95% CI: 1.08–1.89, p = 0.01). Adding muscle asymmetry to a severity-only model improved discrimination from AUC 0.76 to 0.79 (DeLong p = 0.04). A baseline predictive model combining lesion length and muscle asymmetry achieved AUC 0.74; a full explanatory model incorporating longitudinal muscle changes reached AUC 0.88, with the greatest net benefit on decision curve analysis. Conclusion: Thigh muscle biomarkers, acquired opportunistically from routine CTA scans, improved the prediction of 1-year restenosis after endovascular therapy and may support targeted surveillance in patients with unilateral PAD. Key Points: Question Can contralateral-controlled thigh muscle biomarkers on routine CT angiography improve the prediction of 1-year restenosis after endovascular therapy for unilateral peripheral artery disease? Findings In 378 PAD patients, baseline contralateral thigh muscle asymmetry independently predicted clinically driven, DSA-confirmed restenosis and improved AUC from 0.76 to 0.79. Critical relevance statement Opportunistic contralateral-controlled thigh muscle analysis on routine CT angiography provides a no-cost imaging biomarker that refines post-endovascular restenosis risk stratification, supporting targeted angiographic surveillance and advancing personalized vascular imaging practice in peripheral artery disease.
- 7 October 2026
- Published by Springer Nature in Insights into Imaging
- Vol. 17 (1) , 241
Open AccessContralateral-controlled thigh muscle biomarkers on CT angiography for prediction of 1-year restenosis after endovascular therapy for unilateral peripheral artery disease
Objective: To develop and internally validate a model using contralateral-controlled thigh muscle biomarkers, measured on routine computed tomography angiography (CTA), to predict clinically driven, DSA-confirmed 1-year restenosis after endovascular therapy for unilateral peripheral artery disease (PAD). Materials and methods: In this retrospective cohort study, 378 patients with unilateral PAD undergoing endovascular therapy and having baseline and 1-year follow-up CTA were included. Mid-thigh skeletal muscle cross-sectional area and whole-thigh muscle volume were quantified bilaterally with semi-automated software. Contralateral-controlled biomarkers (affected minus contralateral) were derived to isolate limb-specific ischemic effects. The primary endpoint was clinically driven 1-year restenosis (≥ 50%) confirmed by DSA. Results: Among 378 patients, 162 (43%) developed restenosis at a median follow-up of 12.5 months. Contralateral-controlled muscle asymmetry was independently associated with restenosis after adjustment for lesion length, baseline stenosis degree, Fontaine stage, disease duration, and TASC II classification (OR 1.43, 95% CI: 1.08–1.89, p = 0.01). Adding muscle asymmetry to a severity-only model improved discrimination from AUC 0.76 to 0.79 (DeLong p = 0.04). A baseline predictive model combining lesion length and muscle asymmetry achieved AUC 0.74; a full explanatory model incorporating longitudinal muscle changes reached AUC 0.88, with the greatest net benefit on decision curve analysis. Conclusion: Thigh muscle biomarkers, acquired opportunistically from routine CTA scans, improved the prediction of 1-year restenosis after endovascular therapy and may support targeted surveillance in patients with unilateral PAD. Key Points: Question Can contralateral-controlled thigh muscle biomarkers on routine CT angiography improve the prediction of 1-year restenosis after endovascular therapy for unilateral peripheral artery disease? Findings In 378 PAD patients, baseline contralateral thigh muscle asymmetry independently predicted clinically driven, DSA-confirmed restenosis and improved AUC from 0.76 to 0.79. Critical relevance statement Opportunistic contralateral-controlled thigh muscle analysis on routine CT angiography provides a no-cost imaging biomarker that refines post-endovascular restenosis risk stratification, supporting targeted angiographic surveillance and advancing personalized vascular imaging practice in peripheral artery disease.
- Open Access
- 22 July 2026
- Published by Frontiers Media SA in Frontiers in Cardiovascular Medicine
- Vol. 13, 1840464
Aortoileal fistula following endovascular repair of an abdominal aortic aneurysm: a case report
Introduction: Aortoenteric fistula (AEF) following endovascular aortic repair (EVAR) for abdominal aortic aneurysm (AAA) is a rare but severe complication, with most reported cases involving the duodenum, and involvement of the ileum is exceptionally uncommon. Case presentation: We report a rare case of secondary aortoileal fistula with concomitant graft infection in a 66-year-old male, occurring two years after EVAR for AAA. The follow-up imaging 2 years after EVAR showed no aneurysmal sac regression, suggestive of a type II endoleak, which was treated with coil embolization. One week post-embolization, the patient presented with abdominal pain and fever, and a secondary aortoileal fistula was diagnosed. The patient underwent bilateral axillofemoral bypass, excision of the AAA and endograft, and intestinal perforation repair. Intraoperative cultures grew Lactobacillus paracasei. The patient recovered uneventfully and remained well at 1-year follow-up. Conclusion: Aortoileal fistula after EVAR for AAA is an extremely rare yet potentially fatal complication and should be recognized by both clinicians and patients. It may occur as early as 1 month post-operatively or even more than 10 years after EVAR. Appropriate surgical management should be considered on an individual basis to achieve favorable outcomes.
- 22 July 2026
- Published by Frontiers Media SA in Frontiers in Cardiovascular Medicine
- Vol. 13, 1840464
Open AccessAortoileal fistula following endovascular repair of an abdominal aortic aneurysm: a case report
Introduction: Aortoenteric fistula (AEF) following endovascular aortic repair (EVAR) for abdominal aortic aneurysm (AAA) is a rare but severe complication, with most reported cases involving the duodenum, and involvement of the ileum is exceptionally uncommon. Case presentation: We report a rare case of secondary aortoileal fistula with concomitant graft infection in a 66-year-old male, occurring two years after EVAR for AAA. The follow-up imaging 2 years after EVAR showed no aneurysmal sac regression, suggestive of a type II endoleak, which was treated with coil embolization. One week post-embolization, the patient presented with abdominal pain and fever, and a secondary aortoileal fistula was diagnosed. The patient underwent bilateral axillofemoral bypass, excision of the AAA and endograft, and intestinal perforation repair. Intraoperative cultures grew Lactobacillus paracasei. The patient recovered uneventfully and remained well at 1-year follow-up. Conclusion: Aortoileal fistula after EVAR for AAA is an extremely rare yet potentially fatal complication and should be recognized by both clinicians and patients. It may occur as early as 1 month post-operatively or even more than 10 years after EVAR. Appropriate surgical management should be considered on an individual basis to achieve favorable outcomes.
- Open Access
- 3 October 2025
- Published by Wolters Kluwer Health in Medicine
- Vol. 104 (40) , e44871
The predictive model and risk factor identification for peripheral vascular disease and diabetic foot in diabetes based on machine learning models and explainable algorithms
Diabetic peripheral vascular disease (DPVD) and diabetic foot (DF) are major complications that lead to disability in diabetic patients, severely impaired their quality of life. Firstly, this study gathered cross-sectional data from 1240 patients with type 2 diabetes and its complications in the the department of vascular surgery and endocrinology of the second affiliated hospital of zhejiang university school of medicine. In the pre-processing part, samples with serious data loss are eliminated, and the data are processed by methods such as MICEforest. After that, random forest (RF), support vector machine (SVM), backpropagation neural network (BPNN), extreme gradient boosting (XGBoost), and SHapley Additive exPlanation (SHAP) were employed to rank the importance of the 27 indicators. The entropy weight method was then applied to comprehensively assign weights to all indexes. Finally, the genetic neural network algorithm (GA-BPNN) was introduced to construct a prediction model for diabetes complications. In addition, the SHAP algorithm was applied to obtain the weight and importance ranking of each risk factor in the prediction model. This study identified the top 17 key indicators through a comprehensive weighting approach. Among the 5 classification models evaluated, the GA-BPNN algorithm exhibited the best performance in both diabetes and DPVD (G1), DPVD and DF (G2), achieving the area under the receiver operating characteristic curve (AUC) values of 0.79 and 0.89, accuracy rates of 0.78 and 0.80, and F1-scores of 0.77 and 0.83, respectively. Furthermore, hypothesis testing results indicate that indicators such as fibrinogen and c-reactive protein show statistically significant differences between groups. SHAP feature importance analysis also highlights the significant influence of these features in identifying diabetic complications. GA-BPNN can be employed as a prediction model for DPVD and DF. In feature selection, the comprehensive weighting method and SHAP analysis identified key features. In summary, this study constructed a comprehensive prediction model based on machine learning and interpretable algorithms, integrating diabetes-specific indicators, traditional cardiovascular risk factors, coagulation function, inflammatory markers, and cardiac structural parameters. It can effectively identify high-risk patients for diabetic complications, uncover potential features, and thereby assist in subsequent efforts to reduce the incidence of these complications.
- 3 October 2025
- Published by Wolters Kluwer Health in Medicine
- Vol. 104 (40) , e44871
Open AccessThe predictive model and risk factor identification for peripheral vascular disease and diabetic foot in diabetes based on machine learning models and explainable algorithms
Diabetic peripheral vascular disease (DPVD) and diabetic foot (DF) are major complications that lead to disability in diabetic patients, severely impaired their quality of life. Firstly, this study gathered cross-sectional data from 1240 patients with type 2 diabetes and its complications in the the department of vascular surgery and endocrinology of the second affiliated hospital of zhejiang university school of medicine. In the pre-processing part, samples with serious data loss are eliminated, and the data are processed by methods such as MICEforest. After that, random forest (RF), support vector machine (SVM), backpropagation neural network (BPNN), extreme gradient boosting (XGBoost), and SHapley Additive exPlanation (SHAP) were employed to rank the importance of the 27 indicators. The entropy weight method was then applied to comprehensively assign weights to all indexes. Finally, the genetic neural network algorithm (GA-BPNN) was introduced to construct a prediction model for diabetes complications. In addition, the SHAP algorithm was applied to obtain the weight and importance ranking of each risk factor in the prediction model. This study identified the top 17 key indicators through a comprehensive weighting approach. Among the 5 classification models evaluated, the GA-BPNN algorithm exhibited the best performance in both diabetes and DPVD (G1), DPVD and DF (G2), achieving the area under the receiver operating characteristic curve (AUC) values of 0.79 and 0.89, accuracy rates of 0.78 and 0.80, and F1-scores of 0.77 and 0.83, respectively. Furthermore, hypothesis testing results indicate that indicators such as fibrinogen and c-reactive protein show statistically significant differences between groups. SHAP feature importance analysis also highlights the significant influence of these features in identifying diabetic complications. GA-BPNN can be employed as a prediction model for DPVD and DF. In feature selection, the comprehensive weighting method and SHAP analysis identified key features. In summary, this study constructed a comprehensive prediction model based on machine learning and interpretable algorithms, integrating diabetes-specific indicators, traditional cardiovascular risk factors, coagulation function, inflammatory markers, and cardiac structural parameters. It can effectively identify high-risk patients for diabetic complications, uncover potential features, and thereby assist in subsequent efforts to reduce the incidence of these complications.
- Open Access
- 21 August 2025
- Published by Frontiers Media SA in Frontiers in Cardiovascular Medicine
- Vol. 12, 1629547
Case Report: preoperative prediction of aneurysm rupture site using aortic morphological and biomechanical analysis validated by intraoperative imaging
Prediction of aneurysm rupture has been a great challenge for decades. We report a successful rupture site prediction on a 97 mm abdominal aortic aneurysm (AAA). A 73-year-old man with an 11-year history of AAA presented to our outpatient clinic with a one-week history of hemoptysis. After undergoing multidimensional dynamic CTA imaging, the high rupture risk region was predicted through comprehensively inspecting the image-derived characteristics of biomechanics, morphology, and intraluminal thrombus distribution. Owing to financial difficulties, the patient declined treatment. The patient returned to the hospital 140 days later with severe acute abdominal pain. Follow-up CT imaging revealed contrast extravasation accompanied by a large retroperitoneal hematoma, indicating active aneurysmal rupture. Emergency endovascular aneurysm repair (EVAR) was subsequently performed. Notably, the rupture site corresponded to the region previously predicted by our biomechanical analysis and was confirmed intraoperatively via digital subtraction angiography. The patient's postoperative course was uneventful, and he remained in stable condition at the 3-month follow-up. This successful prediction serves as a starting point for verifying the considerations regarding aneurysm rupture mechanism, which would benefits innovative treatment options in future.
- 21 August 2025
- Published by Frontiers Media SA in Frontiers in Cardiovascular Medicine
- Vol. 12, 1629547
Open AccessCase Report: preoperative prediction of aneurysm rupture site using aortic morphological and biomechanical analysis validated by intraoperative imaging
Prediction of aneurysm rupture has been a great challenge for decades. We report a successful rupture site prediction on a 97 mm abdominal aortic aneurysm (AAA). A 73-year-old man with an 11-year history of AAA presented to our outpatient clinic with a one-week history of hemoptysis. After undergoing multidimensional dynamic CTA imaging, the high rupture risk region was predicted through comprehensively inspecting the image-derived characteristics of biomechanics, morphology, and intraluminal thrombus distribution. Owing to financial difficulties, the patient declined treatment. The patient returned to the hospital 140 days later with severe acute abdominal pain. Follow-up CT imaging revealed contrast extravasation accompanied by a large retroperitoneal hematoma, indicating active aneurysmal rupture. Emergency endovascular aneurysm repair (EVAR) was subsequently performed. Notably, the rupture site corresponded to the region previously predicted by our biomechanical analysis and was confirmed intraoperatively via digital subtraction angiography. The patient's postoperative course was uneventful, and he remained in stable condition at the 3-month follow-up. This successful prediction serves as a starting point for verifying the considerations regarding aneurysm rupture mechanism, which would benefits innovative treatment options in future.
- Open Access
- 1 August 2025
- Published by Pleiades Publishing Ltd in Doklady Biochemistry and Biophysics
- Vol. 523 (1) , 424-433
HDAC3 Regulates Ferroptosis via Nrf2–GPX4 Signaling in Colorectal Cancer Cells
Ferroptosis, an iron-dependent form of regulated cell death, represents an emerging therapeutic vulnerability in colorectal cancer (CRC). However, the epigenetic mechanisms controlling ferroptosis sensitivity in CRC remain poorly understood. Here, we identify histone deacetylase 3 (HDAC3) as a pivotal epigenetic suppressor of ferroptosis. Both pharmacological inhibition and genetic knockdown of HDAC3 significantly enhanced ferroptosis sensitivity, as evidenced by elevated intracellular ferrous iron (Fe 2+ ) and lipid peroxidation. Mechanistically, inhibition of HDAC3 reduced the expression of nuclear factor erythroid 2–related factor 2 (NRF2), a master antioxidant transcription factor, thereby leading to downregulation of glutathione peroxidase 4 (GPX4), a central ferroptosis defense gene. Notably, NRF2 knockdown abolished GPX4 downregulation by HDAC3 inhibition, whereas GPX4 overexpression rescued the ferroptotic phenotype caused by HDAC3 depletion. Collectively, these findings define an HDAC3–NRF2–GPX4 axis that suppresses ferroptosis in CRC, and highlight HDAC3 as a potential therapeutic target for ferroptosis-based cancer treatment.
- 1 August 2025
- Published by Pleiades Publishing Ltd in Doklady Biochemistry and Biophysics
- Vol. 523 (1) , 424-433
Open AccessHDAC3 Regulates Ferroptosis via Nrf2–GPX4 Signaling in Colorectal Cancer Cells
Ferroptosis, an iron-dependent form of regulated cell death, represents an emerging therapeutic vulnerability in colorectal cancer (CRC). However, the epigenetic mechanisms controlling ferroptosis sensitivity in CRC remain poorly understood. Here, we identify histone deacetylase 3 (HDAC3) as a pivotal epigenetic suppressor of ferroptosis. Both pharmacological inhibition and genetic knockdown of HDAC3 significantly enhanced ferroptosis sensitivity, as evidenced by elevated intracellular ferrous iron (Fe 2+ ) and lipid peroxidation. Mechanistically, inhibition of HDAC3 reduced the expression of nuclear factor erythroid 2–related factor 2 (NRF2), a master antioxidant transcription factor, thereby leading to downregulation of glutathione peroxidase 4 (GPX4), a central ferroptosis defense gene. Notably, NRF2 knockdown abolished GPX4 downregulation by HDAC3 inhibition, whereas GPX4 overexpression rescued the ferroptotic phenotype caused by HDAC3 depletion. Collectively, these findings define an HDAC3–NRF2–GPX4 axis that suppresses ferroptosis in CRC, and highlight HDAC3 as a potential therapeutic target for ferroptosis-based cancer treatment.
- Open Access
- 24 March 2025
- Published by Baishideng Publishing Group Inc. in World Journal of Clinical Oncology
- Vol. 16 (3) , 101240
Surgical resection of a recurrent retroperitoneal paraganglioma: A case report
BACKGROUND Paraganglioma (PGL) is a neuroendocrine tumor originating from paraganglia that can occur in various locations, such as the head, neck, chest, abdomen, and pelvis. Retroperitoneal PGLs are rare, and recurrent cases in this area are particularly uncommon, posing considerable surgical complexities. Owing to their neuroendocrine activity, PGLs are capable of secreting hormones like catecholamines, thereby presenting significant challenges in hemodynamic management during the perioperative period. CASE SUMMARY We report a 64-year-old man with a recurrent retroperitoneal PGL. The patient underwent retroperitoneal mass resection in 2013, with postoperative pathology revealing a PGL. Regular follow-up was not conducted until April 2024, when a computed tomography scan revealed a huge mass in the retroperitoneum, closely adjacent to the abdominal aorta. Laboratory examinations revealed elevated levels of catecholamines in the patient's blood serum. Upon admission, volume expansion and blood pressure (BP) monitoring were carried out for one week, with catecholamine levels reviewed and normalized. Adequate preoperative preparation was conducted, including central venous access, arterial BP monitoring, and the preparation of vasoactive agents. During tumor resection, the patient experienced acute, significant fluctuations in BP. The timely intervention of the anesthesiologist stabilized the BP, facilitating the successful resection of the tumor which was confirmed as a recurrent PGL. Postoperative follow-up revealed no evidence of tumor residual or recurrence. CONCLUSION PGL recurrence is rare but non-negligible. PGLs adjacent to major arteries complicate surgery, and perioperative hemodynamic stability demands meticulous attention.
- 24 March 2025
- Published by Baishideng Publishing Group Inc. in World Journal of Clinical Oncology
- Vol. 16 (3) , 101240
Open AccessSurgical resection of a recurrent retroperitoneal paraganglioma: A case report
BACKGROUND Paraganglioma (PGL) is a neuroendocrine tumor originating from paraganglia that can occur in various locations, such as the head, neck, chest, abdomen, and pelvis. Retroperitoneal PGLs are rare, and recurrent cases in this area are particularly uncommon, posing considerable surgical complexities. Owing to their neuroendocrine activity, PGLs are capable of secreting hormones like catecholamines, thereby presenting significant challenges in hemodynamic management during the perioperative period. CASE SUMMARY We report a 64-year-old man with a recurrent retroperitoneal PGL. The patient underwent retroperitoneal mass resection in 2013, with postoperative pathology revealing a PGL. Regular follow-up was not conducted until April 2024, when a computed tomography scan revealed a huge mass in the retroperitoneum, closely adjacent to the abdominal aorta. Laboratory examinations revealed elevated levels of catecholamines in the patient's blood serum. Upon admission, volume expansion and blood pressure (BP) monitoring were carried out for one week, with catecholamine levels reviewed and normalized. Adequate preoperative preparation was conducted, including central venous access, arterial BP monitoring, and the preparation of vasoactive agents. During tumor resection, the patient experienced acute, significant fluctuations in BP. The timely intervention of the anesthesiologist stabilized the BP, facilitating the successful resection of the tumor which was confirmed as a recurrent PGL. Postoperative follow-up revealed no evidence of tumor residual or recurrence. CONCLUSION PGL recurrence is rare but non-negligible. PGLs adjacent to major arteries complicate surgery, and perioperative hemodynamic stability demands meticulous attention.
- Top Cited PapersOpen Access
- 21 March 2025
- Published by Frontiers Media SA in Frontiers in Bioengineering and Biotechnology
- Vol. 13, 1556091
Computational fluid dynamics modelling of hemodynamics in aortic aneurysm and dissection: a review
Hemodynamic analysis based on computational fluid dynamics (CFD) modelling is expected to improve risk stratification for patients with aortic aneurysms and dissections. However, the parameter settings in CFD simulations involve considerable variability and uncertainty. Additionally, the exact relationship between hemodynamic features and disease progression remains unclear. These challenges limit the clinical application of aortic hemodynamic models. This review presents a detailed overview of the workflow for CFD-based aortic hemodynamic analysis, with a focus on recent advancements in the field. We also conducted a systematic review of 27 studies with large sample sizes (n > 5) that examine the hemodynamic characteristics of aortic aneurysms and dissections. Some studies identified consistent relationships between hemodynamic features and disease progression, reinforcing the potential for clinical application of aortic hemodynamic models. However, limitations such as small sample sizes and oversimplified patient-specific models remain. These findings emphasize the need for larger, more detailed studies to refine CFD modelling strategies, strengthen the connection between hemodynamics and diseases, and ultimately facilitate the clinical use of aortic hemodynamic models in disease management.
- 21 March 2025
- Published by Frontiers Media SA in Frontiers in Bioengineering and Biotechnology
- Vol. 13, 1556091
Top Cited PapersOpen AccessComputational fluid dynamics modelling of hemodynamics in aortic aneurysm and dissection: a review
Hemodynamic analysis based on computational fluid dynamics (CFD) modelling is expected to improve risk stratification for patients with aortic aneurysms and dissections. However, the parameter settings in CFD simulations involve considerable variability and uncertainty. Additionally, the exact relationship between hemodynamic features and disease progression remains unclear. These challenges limit the clinical application of aortic hemodynamic models. This review presents a detailed overview of the workflow for CFD-based aortic hemodynamic analysis, with a focus on recent advancements in the field. We also conducted a systematic review of 27 studies with large sample sizes (n > 5) that examine the hemodynamic characteristics of aortic aneurysms and dissections. Some studies identified consistent relationships between hemodynamic features and disease progression, reinforcing the potential for clinical application of aortic hemodynamic models. However, limitations such as small sample sizes and oversimplified patient-specific models remain. These findings emphasize the need for larger, more detailed studies to refine CFD modelling strategies, strengthen the connection between hemodynamics and diseases, and ultimately facilitate the clinical use of aortic hemodynamic models in disease management.
- Open Access
- 25 August 2023
- Published by Wolters Kluwer Health in Medicine
- Vol. 102 (34) , e34688
Comparison of oxybuprocaine and lidocaine topical anesthesia for pain control in radiofrequency ablation treatment of great saphenous vein insufficiency
Topical anesthetics have been used for radiofrequency ablation of great saphenous vein insufficiency. A total of 74 patients with great saphenous vein insufficiency treated at our center between February 2021 and August 2022 were enrolled. The patients were selected and divided into an oxybuprocaine group(n = 30) and a lidocaine group (n = 44). The visual analogue scale (VAS) was used to evaluate intraoperative and postoperative pain. Patient satisfaction with anesthesia, maintenance time of anesthesia, and disturbance of the surgeons were also recorded and assessed. The VAS scores and other indices of the 2 groups were compared to assess the effectiveness of anesthesia. Perioperative surgical complications and painkiller use were also recorded. The median VAS score of the patients during the process was 2 in both groups, and the difference between the groups was not statistically significant. In the 2 groups, 93.33% of the patients in the oxybuprocaine group and 93.18% of the patients in the lidocaine group were satisfed with the anesthesia. Nine patients in the lidocaine group and 14 in the oxybuprocaine group received additional anesthetic drugs. The average maintenance time of anesthesia was longer in the lidocaine group. No serious complications occurred in either of the groups. Both oxybuprocaine and lidocaine topical anesthesia combined with tumescent anesthesia could provide effective pain control in radiofrequency ablation treatment of great saphenous vein insufficiency. Although the average maintenance time of anesthesia was longer in the lidocaine group, there was no difference in the associated complications and pain control.
- 25 August 2023
- Published by Wolters Kluwer Health in Medicine
- Vol. 102 (34) , e34688
Open AccessComparison of oxybuprocaine and lidocaine topical anesthesia for pain control in radiofrequency ablation treatment of great saphenous vein insufficiency
Topical anesthetics have been used for radiofrequency ablation of great saphenous vein insufficiency. A total of 74 patients with great saphenous vein insufficiency treated at our center between February 2021 and August 2022 were enrolled. The patients were selected and divided into an oxybuprocaine group(n = 30) and a lidocaine group (n = 44). The visual analogue scale (VAS) was used to evaluate intraoperative and postoperative pain. Patient satisfaction with anesthesia, maintenance time of anesthesia, and disturbance of the surgeons were also recorded and assessed. The VAS scores and other indices of the 2 groups were compared to assess the effectiveness of anesthesia. Perioperative surgical complications and painkiller use were also recorded. The median VAS score of the patients during the process was 2 in both groups, and the difference between the groups was not statistically significant. In the 2 groups, 93.33% of the patients in the oxybuprocaine group and 93.18% of the patients in the lidocaine group were satisfed with the anesthesia. Nine patients in the lidocaine group and 14 in the oxybuprocaine group received additional anesthetic drugs. The average maintenance time of anesthesia was longer in the lidocaine group. No serious complications occurred in either of the groups. Both oxybuprocaine and lidocaine topical anesthesia combined with tumescent anesthesia could provide effective pain control in radiofrequency ablation treatment of great saphenous vein insufficiency. Although the average maintenance time of anesthesia was longer in the lidocaine group, there was no difference in the associated complications and pain control.